Slowly progressive retinitis pigmentosa caused by two novel mutations in the MAK gene

References

• Van Huet RAC, Collin RWJ, Siemiatkowska AM, Klaver CCW, Hoyng CB, Simonelli F, Khan MI, Qamar R, Banin E, Cremers FPM, et al. IMPG2-associated retinitis pigmentosa displays relatively early macular involvement. Investig Ophthalmol Vis Sci. 2014;55(6):3939–53. doi:10.1167/iovs.14-14129.
   PubMed Web of Science ®Google Scholar
• Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Genet Couns. 2006;368(9549):1795–809.
   Google Scholar
• Bainbridge JWB, Smith AJ, Barker SS, Robbie S, Henderson R, Balaggan K, Viswanathan A, Holder GE, Stockman A, Tyler N, et al. Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med. 2008;(358):2231–39. doi:10.1056/NEJMoa0802268.
   PubMed Web of Science ®Google Scholar
• Maguire AM, Simonelli F, Pierce EA, Pugh EN, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, et al. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med. 2008;358(21):2240–48. doi:10.1056/NEJMoa0802315.
   PubMed Web of Science ®Google Scholar
• Hauswirth WW, Aleman TS, Kaushal S, Cideciyan AV, Schwartz SB, Wang L, Conlon TJ, Boye SL, Flotte TR, Byrne BJ, et al. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther. 2008;19(10):979–90. doi:10.1089/hum.2008.107.
   PubMed Web of Science ®Google Scholar
• MacLaren RE, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Seymour L, Clark KR, During MJ, Cremers FPM, Black GCM, et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet. 2014;383(9923):1129–37. doi:10.1016/S0140-6736(13)62117-0.
   PubMed Web of Science ®Google Scholar
• Matsushime H, Jinno A, Takagi N, Shibuya M. A novel mammalian protein kinase gene (mak) is highly expressed in testicular germ cells at and after meiosis. Mol Cell Biol. 1990;10(5):2261–68. http://www.ncbi.nlm.nih.gov/pubmed/2183027.
   PubMed Web of Science ®Google Scholar
• Omori Y, Chaya T, Katoh K, Kajimura N, Sato S, Muraoka K, Ueno S, Koyasu T, Kondo M, Furukawa T. Negative regulation of ciliary length by ciliary male germ cell-associated kinase (Mak) is required for retinal photoreceptor survival. Proc Natl Acad Sci U S A. 2010;107(52):22671–76. doi:10.1073/pnas.1009437108.
   PubMed Web of Science ®Google Scholar
• Özgül RK, Siemiatkowska AM, Yücel D, Myers CA, Collin RWJ, Zonneveld MN, Beryozkin A, Banin E, Hoyng C, van den Born L, et al. Exome sequencing and cis-regulatory mapping identify mutations in MAK, a gene encoding a regulator of ciliary length, as a cause of retinitis pigmentosa. Am J Hum Genet. 2011;89(2):253–64. doi:10.1016/j.ajhg.2011.07.005.
   PubMed Web of Science ®Google Scholar
• Tucker BA, Scheetz TE, Mullins RF, DeLuca AP, Hoffmann JM, Johnston RM, Jacobson SG, Sheffield VC, Stone EM. Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci U S A. 2011;108(34):E569–76. doi:10.1073/pnas.1108918108
   Web of Science ®Google Scholar
• Stone EM, Luo X, Héon E, Lam BL, Weleber RG, Halder JA, Affatigato LM, Goldberg JB, Sumaroka A, Schwartz SB, et al. Autosomal recessive retinitis pigmentosa caused by mutations in the MAK gene. Investig Ophthalmol Vis Sci. 2011;52(13):9665–73. doi:10.1167/iovs.11-8527.
   PubMed Web of Science ®Google Scholar
• Van Huet RAC, Siemiatkowska AM, Özgül RK, Yucel D, Hoyng CB, Banin E, Blumenfeld A, Rotenstreich Y, Riemslag FCC, Den Hollander AI, et al. Retinitis pigmentosa caused by mutations in the ciliary MAK gene is relatively mild and is not associated with apparent extra-ocular features. Acta Ophthalmol. 2015;93(1):83–94. doi:10.1111/aos.12500.
   PubMed Web of Science ®Google Scholar
• Kimchi A, Khateb S, Wen R, Guan Z, Obolensky A, Beryozkin A,Kurtzman S, Blumenfeld A, Pras E, Jacobson SG, et al. Nonsyndromic retinitis pigmentosa in the Ashkenazi Jewish population: Genetic and clinical aspects. Ophthalmology. 2018;125(5):725–734. doi:10.1016/j.ophtha.2017.11.014.
   PubMed Web of Science ®Google Scholar
• Wallis Y, Payne S, McAnulty C, Bodmer D. Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics. London: Association for Clinical Genetic Science; 2013. 16 p.
   Google Scholar
• Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T, O’Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91. doi:10.1038/nature19057.
   PubMed Web of Science ®Google Scholar
• Lai Y-H, Capasso JE, Kaiser R, Levin AV. Intraretinal cystoid spaces in a patient with retinitis pigmentosa due to mutation in the MAK gene. Ophthalmic Genet. 2016;37(4):424–426. doi:10.3109/13816810.2015.1092046.
   PubMed Web of Science ®Google Scholar
• Tucker BA, Scheetz TE, Mullins RF, DeLuca AP, Hoffmann JM, Johnston RM, Jacobson SG, Sheffield VC, Stone EM. Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci. 2011;108(34):E569–76. doi:10.1073/pnas.1108918108.
   PubMed Web of Science ®Google Scholar
• Batzer MA, Stoneking M, Alegria-Hartman M, Bazan H, Kass DH, Shaikh TH, Novick GE, Ioannou PA, Scheer WD, Herrera RJ. African origin of human-specific polymorphic Alu insertions. Proc Natl Acad Sci U S A. 1994;91(December):12288–92. doi:10.1073/pnas.91.25.12288.
   PubMed Web of Science ®Google Scholar
• Stoneking M, Fontius JJ, Clifford SL, Soodyall H, Arcot SS, Saha N, Jenkins T, Tahir MA, Deininger PL, Batzer MA. Alu insertion polymorphisms and human evolution: evidence for a larger population size in Africa. Genome Res. 1997;7:1061–71. doi:10.1101/gr.7.11.1061.
   PubMed Web of Science ®Google Scholar
• Venturini G, Koskiniemi-Kuendig H, Harper S, Berson EL, Rivolta C. Two specific mutations are prevalent causes of recessive retinitis pigmentosa in North American patients of Jewish ancestry. Genet Med. 2014;17(4):285–90. doi:10.1038/gim.2014.132.
   PubMed Web of Science ®Google Scholar
• Mount SM. A catalogue of splice junction sequences. Nucleic Acids Res. 1982;10(21082):459–72. doi:10.1093/nar/10.2.459.
   PubMed Web of Science ®Google Scholar
• Ruskin B, Green MR. Role of the 3′ splice site consensus sequence in mammalian pre-mRNA splicing. Nature. 1985;316:452–57.
   PubMed Web of Science ®Google Scholar
• Mcclements ME, Maclaren RE. Europe PMC funders group gene therapy for retinal disease. Translational Research. 2013;161(4):241–254.
   Google Scholar
• Edwards TL, Jolly JK, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Black GC, Webster AR, Lotery AJ, Holder GE, et al. Visual acuity after retinal gene therapy for choroideremia. N Engl J Med. 2016;374(20):1996–8. doi:10.1056/NEJMc1509501.
   Web of Science ®Google Scholar
• Weleber RG, Pennesi ME, Wilson DJ, Kaushal S, Erker LR, Jensen L, McBride MT, Flotte TR, Humphries M, Calcedo R, et al. Results at 2 years after gene therapy for RPE65-deficient leber congenital amaurosis and severe early-childhood-onset retinal dystrophy. Ophthalmology. Ophthalmology 2016;123:1606–20. doi:10.1016/j.ophtha.2016.03.003.
   Web of Science ®Google Scholar